Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial

Navi, B. B., Zhang, C., Miller, B., Cushman, M., Kasner, S. E., Elkind, M. S. V., Tirschwell, D. L., Longstreth, W. T., Kronmal, R. A., Beyeler, M., Elm, J., Zweifler, R. M., Tarsia, J., Cereda, C. W., Bianco, G., Costamagna, G., Michel, P., Broderick, J. P., Gladstone, D. J., … Streib, C. (2024). Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke. JAMA Neurology, 81(9), 958. https://doi.org/10.1001/jamaneurol.2024.2404
Authors:
Babak B Navi
Cenai Zhang
Benjamin Miller
Mary Cushman
Scott E Kasner
Mitchell S V Elkind
David L Tirschwell
W T Longstreth
Richard A Kronmal
Morin Beyeler
Jordan Elm
Richard M Zweifler
Joseph Tarsia
Carlo W Cereda
Giovanni Bianco
Gianluca Costamagna
Patrik Michel
Joseph P Broderick
David J Gladstone
Hooman Kamel
Christopher Streib
Affiliated Authors:
Mitchell S V Elkind
Columbia Affiliation:
Subjects:
Pyridones (MeSH)
Aspirin (MeSH)
Neoplasms (MeSH)
Pyrazoles (MeSH)
Ischemic Stroke (MeSH)
Factor Xa Inhibitors (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1001/jamaneurol.2024.2404
PMID:
39133474
DOI:
10.1001/jamaneurol.2024.2404
Journal:
JAMA Neurology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: